Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRBP
DateTimeSourceHeadlineSymbolCompany
05/15/20198:05AMGlobeNewswire Inc.Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in MayNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/14/20191:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/14/20199:47AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/09/20198:06AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/09/20197:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/09/20197:00AMGlobeNewswire Inc.Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/02/20198:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic SclerosisNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/01/20198:05AMGlobeNewswire Inc.Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on...NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/29/201912:32PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/18/20199:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/18/20198:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study in Systemic Sclerosis in U.S. ...NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/10/20194:07PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/10/20194:06PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/08/20194:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/08/20194:42PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/08/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/08/20198:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Appoints Rachelle Jacques to Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/01/20194:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/28/20198:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Provides Management Team UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/18/20199:48AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/15/201911:11AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/15/201910:34AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/14/20192:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/14/20191:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/14/201911:27AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/12/20199:28AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/12/20197:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/12/20197:00AMGlobeNewswire Inc.Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/07/20198:00AMGlobeNewswire Inc.Corbus Pharmaceuticals to Announce Full-Year 2018 Operational and Financial Results on March 12, 2019NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/20196:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRBP